The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
Last updated
Peptide Profile

Bezafibrate: Research, Dosing, and Where to Buy in 2026

A research-first profile for Bezafibrate (bzzo vibrate, bzzalip, Bezalip), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.

⚕️ US PRESCRIPTION REQUIRED. Bezafibrate is a prescription medication in the United States. Prescription and controlled-substance rules differ by country, so check your local laws before any purchase or use. Information on this page is educational and not medical advice. Consult a licensed prescribing physician.
Quick Answer

Bezafibrate is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 1 transcript dosing protocol for Bezafibrate, each linked to its source.

Key Facts
Pharmaceutical
  • Also indexed as bzzo vibrate, bzzalip, Bezalip.
  • 1 aggregated dosing-protocol mention from source transcripts.
  • 8 PubMed-indexed citations listed in the research table below.
  • 0 vendor recommendations captured from named experts.
Sourced to expert
Check vendor COA
Verify dose w/ clinician

What is Bezafibrate?

Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.

Bezafibrate Dosing Protocols

The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.

SpeakerSourceTimestampProtocolEvidence
Vigorous Steve Skyrocket Your Energy Levels With ATP Synthesis And Mitochondrial Enhancement 00:09:59 Indicated for mitochondrial disorders; not recommended for those with healthy mitochondria anecdotal

Where to Buy Bezafibrate in 2026

No tracked vendor recommendations for Bezafibrate yet. See our vendor directory.

Side Effects and Safety

Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.

User Reviews

User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.

Research Efficacy Snapshot

Published efficacy percentages cited in PubMed trials and named-expert reports about Bezafibrate. Each line links to the original source.

  • "In gastrocnemius muscle, immobilization reduced muscle weight by an average of ~ 17.2%, and bezafibrate treatment prevented ~ 40.5% of that atrophy." · Nakamura S et al, 2024 PubMed
  • "RevMan Analysis was used for statistical analysis of dichotomous data with risk ratio (RR) or risk difference (RD), and of continuous data with mean difference (MD), both with 95% confidence intervals (CI)." · Rudic J et al, 2012 PubMed
  • "Bezafibrate significantly decreased the activity of serum alkaline phosphatases compared with no intervention (MD -186.04 U/L, 95% CI -249.03 to -123.04; 4 trials with 79 patients; I² = 34%) and when compared with UDCA (MD -162.90 U/L, 95% CI -199.68 to -126.12; 2 trials with 48 patients; I² = 0%)." · Rudic J et al, 2012 PubMed
  • "Bezafibrate compared with no intervention significantly decreased plasma immunoglobulin M (MD -164.00 mg/dl, 95% CI -259.47 to -68.53; 3 trials with 50 patients; I² = 46%) and serum bilirubin concentration (MD -0.19 mg/dl, 95% CI -0.38 to -0.00; 2 trials with 34 patients; I² = 0%)." · Rudic J et al, 2012 PubMed
  • "Bezafibrate compared with no intervention had no significant effect on the activity of serum gamma-glutamyltransferase (MD -1.22 U/L, 95% CI -11.97 to 9.52; 4 trials with 79 patients; I² = 42%) and serum alanine aminotransferase (MD -5.61 U/L, 95% CI -24.50 to 13.27; 2 trials with 35 patients; I² = 34%)." · Rudic J et al, 2012 PubMed
  • "One patient had bezafibrate withdrawn due to an adverse event compared to no intervention (RD 0.03, 95% CI -0.09 to 0.16; 2 trials with 60 patients; I² = 0%)." · Rudic J et al, 2012 PubMed

Research and Studies

8 PubMed-indexed papers reference Bezafibrate. Top 8 shown.

PMID 6628234
Drug and therapeutics bulletin
1983

Frequently Asked Questions

Is Bezafibrate FDA-approved?

Bezafibrate is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.

What dosing is reported for Bezafibrate?

This page aggregates 1 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.

How much research has been published on Bezafibrate?

8 PubMed-indexed paper(s) reference Bezafibrate in our current research feed. See the Research and Studies section above for citations.